Kiro is a French start-up that is on a mission to revolutionize healthcare by utilizing the power of artificial intelligence. The company has secured Series A funding of $14,955,000 from notable investors, including Bpifrance, Sofinnova Partners, Propulia Capital, and Kurma Partners.

Kiro aims to improve patient care by providing understandable and relevant information to patients and doctors alike. They believe that medical biology is at the heart of healthcare, and it plays a crucial role in diagnosing, treating, and preventing diseases. By fostering the interaction between laboratories, health professionals, and patients, Kiro aims to go beyond the results and provide personalized patient care.

The company has worked closely with clinical biologists, doctors, and medical experts to develop a new approach to medical biology that is more understandable and personalized for patients. With the help of artificial intelligence, Kiro can provide patients with relevant and reliable information, improving their overall health and well-being.

Kiro's innovative solutions will change the face of healthcare in the coming years. With the backing of prominent investors, the company make a significant impact in the industry. As they continue to develop new technologies and solutions, Kiro is poised to lead the way in patient-centric healthcare. Visit our Latest funding round for more information: https://founderlodge.com/round/Kiro-raises-14955000-Series-A-2023-04-03-Alexandre-Guenoun-MTE4NjQ